Management of pain in multiple sclerosis: a pharmacological approach

Claudio Solaro1, Michele Messmer Uccelli

  • 1Department of Neurology, PA Micone Hospital, ASL3 Genovese, Via Oliva 22, Genoa, 16153, Italy. csolaro@libero.it

Insights

Pain is common in multiple sclerosis (MS), affecting about half of patients and impacting daily life. Current pain management strategies for MS lack robust evidence due to study limitations.

Area of Science:

  • Neurology
  • Pain Medicine
  • Pharmacology

Background:

  • Pain affects approximately 50% of individuals with multiple sclerosis (MS).
  • Pain management in MS accounts for a significant portion (nearly 30%) of all MS-related medication use.
  • MS-associated pain can co-occur with other symptoms like spasticity, fatigue, and mood disorders, significantly disrupting patients' quality of life.

Purpose of the Study:

  • To review current pharmacological treatments for pain in multiple sclerosis.
  • To highlight the limitations and shortcomings in existing research on MS pain management.

Main Methods:

  • Review of available clinical evidence on pharmacological approaches for MS pain.
  • Analysis of study designs, sample sizes, and ethical considerations in pain management research for MS.

Main Results:

  • The majority of evidence for MS pain treatments comes from small, open-label studies.
  • Insufficient high-quality evidence exists to definitively support or refute the efficacy of many pain medications for MS.
  • Clinical features of MS pain are often underrecognized by clinicians and difficult for patients to articulate.

Conclusions:

  • Current pharmacological management of pain in multiple sclerosis is often based on limited evidence and clinical experience.
  • There is a critical need for more rigorous, large-scale, and placebo-controlled studies to guide effective MS pain treatment.
  • Addressing the complexities of MS pain and improving patient-reported outcomes requires better research methodologies.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...